Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Volume 388. Lancet; 2016. p. 1081. (London, England).
Sonderup MW, Spearman CW. Global disparities in hepatitis B elimination—a focus on Africa. Viruses. 2022;14:82.
Nasir M, Wu GY. HEV and HBV dual infection: a review. J Clin Transl Hepatol. 2020;8:1–9.
Nghiem Xuan Hoan, Van Tong H, Hecht N, Sy BT, Marcinek P, Meyer CG, et al. Hepatitis E virus superinfection and clinical progression in hepatitis B patients. EBioMedicine. 2015;2:2080–6.
Kilonzo SB, Gunda D, Ning Q, Han M. Where hepatitis B and hepatitis E meet: epidemiological and clinical aspects. Hepat Monthly. 2019;19(10):e93840. https://doi.org/10.5812/hepatmon.93840
Huang X-J, Choi Y-K, Im H-S, Yarimaga O, Yoon E, Kim H-S. Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques. Sensors (Basel, Switzerland) [Internet]. 2006;6:756–82. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894536/
Lala V, Zubair M, Minter DA. Liver Function Tests [Internet]. Nih.gov. StatPearls Publishing; 2023 [cited 2024 Aug 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK482489/
Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, et al. Occult hepatitis B virus infection in Nigerian blood donors and hepatitis B virus transmission risks. PLOS ONE. 2015;10:e0131912.
Wang B, Harms D, Papp CP, Niendorf S, Jacobsen S, Lütgehetmann M, Pischke S, Wedermeyer H, Hofmann J, Bock C 2018. Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants. J Clin Microbiol 56:e01686. https://doi.org/10.1128/JCM.01686-17
Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4.
Okwara VC, Mbachu II, Ndububa VI, Okpara HC, Mbachu CP, Seroprevalence. Associated Factors, and Fetomaternal Outcome in Pregnant Women That Tested Positive to Hepatitis E Antibodies in Nigeria. Chigusa Y, editor. Obstetrics and Gynecology International. 2021;2021:1–8.
Ola SO, Odaibo GN, Olaleye OD, Ayoola EA. Hepatitis B and E viral infections among Nigerian healthcare workers. PubMed. 2012;41:387–91.
Meng X, Halbur PG, Shapiro M, Govindarajan S, Bruna J, Mushahwar IK, et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol. 1998;72:9714–21.
Buisson Y, Grandadam M, Coursaget P, Cheval P, Rehel P, Nicand E, et al. Identification of a novel hepatitis E virus in Nigeria. J Gen Virol. 2000;81:903–9.
Akanbi OA, Harms D, Wang B, Opaleye OO, Adesina O, Osundare FA, Ogunniyi A, Naidoo D, Devaux I, Wondimagegnehu A, Peter C, Ifeanyi O, Ogundiran O, Ugochukwu U, Mba N, Omilabu SA, Ihekweazu C, Bock C. Complete Genome Sequence of a Hepatitis E Virus Genotype 1e Strain from an Outbreak in Nigeria, 2017. Microbiol Resour Announc 2019;8(1):10–128. https://doi.org/10.1128/mra.01378-18
Wang B, Akanbi OA, Harms D, Adesina O, Osundare FA, Naidoo D, Deveaux I, Ogundiran O, Ugochukwu U, Mba N, Ihekweazu C, Bock CT. A new hepatitis E virus genotype 2 strain identified from an outbreak in Nigeria, 2017. Virol J. 2018;15(1):163. https://doi.org/10.1186/s12985-018-1082-8
Iloh GP, Ikwudinma A. Sero-epidemiology of hepatitis B surface antigenaemia among adult Nigerians with clinical features of liver diseases attending a primary-care clinic in a resource-constrained setting of Eastern Nigeria. North Am J Med Sci. 2013;5:293.
Lin C-L, Kao J-H. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5:a021436–6.
Forbi JC, Vaughan G, Purdy MA, Campo DS, Xia G, Ganova-Raeva LM, et al. Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS ONE. 2010;5:e11615.
Opaleye OO, Japhet OM, Adewumi OM et al. Ewean Chukwuma Omoruyi, Olusola Anuoluwapo Akanbi, Adeolu Sunday Oluremi,. Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria. Virol J. 2016;13.
Makvandi M. Update on occult hepatitis B virus infection. World Journal of Gastroenterology [Internet]. 2016 [cited 2020 Oct 2];22:8720–34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075547/
Opaleye OO, Oluremi AS, Atiba AB, Adewumi MO, Mabayoje OV, Donbraye E, et al. Occult hepatitis B virus infection among HIV positive patients in Nigeria. J Trop Med. 2014;2014:1–5.
Akintule OA, Olusola BA, Odaibo GN, Olaleye DO. Occult HBV infection in Nigeria. PubMed. 2018;6:87–93.
Olotu AA, Oyelese AO, Salawu L et al. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J. 2016;13:76. https://doi.org/10.1186/s12985-016-0533-3
Li P, Liu J, Li Y, Su J, Ma Z, Bramer WM, et al. The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis. Liver Int. 2020;40:1516–28.
Singh, A., Singh, S., Ansari, M.A. et al. Co-infectivity of hepatitis B virus and hepatitis E virus. BMC Infect Dis 2012;12(Suppl 1):P1. https://doi.org/10.1186/1471-2334-12-S1-P1
McGivern DR, Lin HH, Wang J, Benzine T, Janssen HL, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW. Prevalence and impact of hepatitis E virus infection among persons with chronic hepatitis B living in the US and Canada. In: Open Forum Infectious Diseases 2019 May (Vol. 6, No. 5, p. ofz175). US: Oxford University Press. https://doi.org/10.1093/ofid/ofz175
Thakur S, Kumar V, Das R, Sharma V. Dinesh Kumar Mehta. Biomarkers of hepatic toxicity: an overview. Curr Therapeutic Res. 2024;100:100737–7.
Kolahdoozan S, Mirminachi B, Sepanlou SG, Malekzadeh R, Merat S, Poustchi H. Upper normal limits of serum alanine aminotransferase in healthy population: a systematic review. Middle East J Dig Dis. 2020;12:194–205.